Related references
Note: Only part of the references are listed.Use of Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)-(Equine) (BAT(R)) in Clinical Study Subjects and Patients: A 15-Year Systematic Safety Review
Geraldine S. Parrera et al.
TOXINS (2022)
A Single Animal Species-Based Prediction of Human Clearance and First-in-Human Dose of Monoclonal Antibodies: Beyond Monkey
Iftekhar Mahmood
ANTIBODIES (2021)
Safety and Clinical Outcomes of an Equine-derived Heptavalent Botulinum Antitoxin Treatment for Confirmed or Suspected Botulism in the United States
Jason S. Richardson et al.
CLINICAL INFECTIOUS DISEASES (2020)
Target-Mediated Drug Disposition Pharmacokinetic/Pharmacodynamic Model-Informed Dose Selection for the First-in-Human Study of AVB-S6-500
Laura Bonifacio et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2020)
Efficacy of equine botulism antitoxin in botulism poisoning in a guinea pig model
Andrew Emanuel et al.
PLOS ONE (2019)
Influence of Molecular size on the clearance of antibody fragments
Zhe Li et al.
PHARMACEUTICAL RESEARCH (2017)
Identification and characterization of a novel botulinum neurotoxin
Sicai Zhang et al.
NATURE COMMUNICATIONS (2017)
Therapeutic efficacy of equine botulism antitoxin in Rhesus macaques
Shantha Kodihalli et al.
PLOS ONE (2017)
Establishing Good Practices for Exposure-Response Analysis of Clinical Endpoints in Drug Development
R. V. Overgaard et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2015)
Second-generation minimal physiologically-based pharmacokinetic model for monoclonal antibodies
Yanguang Cao et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2013)
Botulinum Neurotoxin: A Marvel of Protein Design
Mauricio Montal
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 79 (2010)
Prediction of Human Clearance of Therapeutic Proteins: Simple Allometric Scaling Method Revisited
Weirong Wang et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2010)
Use of pharmacokinetic/pharmacodynamic modelling for starting dose selection in first-in-human trials of high-risk biologics
Balaji M. Agoram
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Interspecies Scaling of Therapeutic Monoclonal Antibodies: Initial Look
Jie Ling et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Botulism in 4 adults following cosmetic injections with an unlicensed, highly concentrated botulinum preparation
Daniel S. Chertow et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
An outbreak of botulism in Thailand: Clinical manifestations and management of severe respiratory failure
Subsai Kongsaengdao et al.
CLINICAL INFECTIOUS DISEASES (2006)
An initial assessment of the systemic pharmacokinetics of botulinum toxin
Easwaran Ravichandran et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Human botulism immune globulin for the treatment of infant botulism
SS Arnon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Early antitoxin treatment in wound botulism results in better outcome
GY Chang et al.
EUROPEAN NEUROLOGY (2003)
Botulinum toxin as a biological weapon - Medical and public health management
SS Arnon et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
